Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10,730 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.
Mohamed YI, Duda DG, Awiwi MO, Lee SS, Altameemi L, Xiao L, Morris JS, Wolff RA, Elsayes KM, Hatia RI, Qayyum A, Chamseddine SM, Rashid A, Yao JC, Mahvash A, Hassan MM, Amin HM, Kaseb AO. Mohamed YI, et al. Among authors: yao jc. Oncotarget. 2022 Dec 6;13:1314-1321. doi: 10.18632/oncotarget.28322. Oncotarget. 2022. PMID: 36473155
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.
Pan G, Zhong M, Yao J, Tan J, Zheng H, Jiang Y, Tang Y, Zhou H, Qin D, Yu X, Liu L, Li Z, Lin Z, Jiang Y, Xu B, Zha J. Pan G, et al. Among authors: yao j. J Cancer Res Clin Oncol. 2022 Dec 6. doi: 10.1007/s00432-022-04473-5. Online ahead of print. J Cancer Res Clin Oncol. 2022. PMID: 36471019
10,730 results
You have reached the last available page of results. Please see the User Guide for more information.